This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

Residual Symptoms and the Risk of Relapse in Major Depression

Michael E. Thase, MD

Published: November 15, 2013

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Numerous treatments exist today to help patients who suffer from major depressive disorder, which is one of the world’s leading causes of disability. However, limitations to these first-line treatments exist. Due to these limitations, some patients may not reach remission after acute treatment, potentially causing them to relapse back into a depressive state. Residual depressive symptoms also impact patients’ workplace functioning and interpersonal relationships. Clinicians should consider the numerous possible reasons for inadequate response to treatment and decide whether to switch medications or augment. While many patients do experience recovery from depression, the limitations of current first-line treatments show a need for new antidepressant therapy that is safe and effective.


 

Related Articles

Volume: 74

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...